Azelaic Acid for Rosacea: What the Science Says

Azelaic acid is one of the best-studied topical options for inflammatory (papulopustular) rosacea. Prescription 15% gel and foam formulations have been tested in large randomized trials. Across those studies, many people saw fewer papules and pustules and, for some, improved facial redness — usually over about 12–15 weeks of twice-daily use. It is not a cure, and results vary by person.

What is azelaic acid used for in rosacea?

Clinicians mainly use azelaic acid for papules and pustules. It has anti-inflammatory and antimicrobial activity and may affect pathways linked to rosacea inflammation (including aspects of the cathelicidin pathway discussed in dermatology literature). It is not primarily a treatment for fixed visible vessels (telangiectasia). For how approaches differ from acne care, see rosacea vs acne treatment.

Phase III evidence: two placebo-controlled trials (n = 664)

Thiboutot and colleagues published two identical-design, multicenter, double-blind, randomized, placebo-controlled phase III studies of 15% azelaic acid gel twice daily for 12 weeks in moderate papulopustular rosacea (Journal of the American Academy of Dermatology, 2003). In trial language the inactive comparator is often called a “vehicle” gel — the same base without azelaic acid:

• Study 1: 329 adults enrolled across 13 U.S. centers.
• Study 2: 335 adults enrolled across 14 U.S. centers.
• Combined enrollment: 664 people.
• Design: parallel-group, placebo-controlled (inactive gel), twice-daily application.

Key results vs placebo gel (percentages from the trials)

All of those differences favored azelaic acid gel and were reported as statistically significant in the published JAAD report. No serious treatment-related adverse events were reported in those trials; local sensory symptoms (such as burning or stinging) can still occur and are discussed with patients in practice.

Compared with metronidazole: randomized trial (n = 251)

Elewski and colleagues ran a multicenter, double-blind, randomized trial of 251 people with papulopustular rosacea, persistent erythema, and telangiectasia (Archives of Dermatology / JAMA Dermatology network, 2003). Participants used 15% azelaic acid gel or 0.75% metronidazole gel twice daily for 15 weeks.

• Mean percent drop in inflammatory lesions: 72.7% with azelaic acid vs 55.8% with metronidazole.
• Mean change in lesion count: −12.9 vs −10.7 lesions.
• Erythema rated improved: 56% (azelaic acid) vs 42% (metronidazole).
• Neither treatment produced a clinically appreciable effect on telangiectasia in that study.
• Metronidazole’s average benefit on the measured lesion variables appeared to plateau after about week 8, while azelaic acid showed continued average improvement through week 15 in the published analysis.

What systematic reviews add

A Cochrane phenotype-based systematic review of rosacea interventions (updated evidence synthesis including GRADE) reported high-certainty evidence that topical azelaic acid reduces papules and pustules. Family-medicine summaries drawing on that evidence have described marked-to-excellent patient-rated improvement more often with 15–20% azelaic acid than with placebo (number needed to treat around 6 in one AAFP synthesis). That supports azelaic acid as a first-line topical option for inflammatory lesions — not as a universal fix for every rosacea feature.

Prescription vs over-the-counter

The pivotal rosacea data above are for prescription-strength 15% gel (and related prescription foam products studied later for papulopustular rosacea). Over-the-counter products are often lower strength and different bases or formulas; they are not interchangeable with the trial formulations. A clinician can advise whether a prescription product fits your pattern and how to introduce it if your barrier is reactive.

Practical use notes (not a DIY protocol)

• Trial regimens were typically twice daily for 12–15 weeks before judging effect.
• Pair with a gentle cleanser, moisturizer, and daily SPF — the same foundation as a rosacea-friendly routine.
• Mild warm or tingle at first is common; persistent burning or severe irritation means stop and check with a clinician.
• Do not stack multiple strong acne actives on top without medical advice — that is a frequent flare trigger.

For barrier-first daily care, see building a rosacea-friendly skincare routine. For the bump pattern azelaic acid is often aimed at, see papulopustular rosacea.